Five former leaders of Large Scale Biology subsidiary Predictive Diagnostics have co-founded Advanced Ideas in Medicine a new company that, like Predictive, focuses on proteomic-based diagnostics for the early detection of cancer.
Though AIM has similar goals to Predictive, it is based on a "completely different" technology, said Guy della Cioppa, the head of business development at AIM who served as senior vice president of business development at Predictive for two years, before leaving the company in June.